{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:09:05Z","timestamp":1783699745697,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.drugalcdep.2015.03.039","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T21:24:56Z","timestamp":1429133096000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006\u20132013"],"prefix":"10.1016","volume":"152","author":[{"given":"Ashly E.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Arasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection","volume":"44","author":"Alter","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0010","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology and burden of Hepatitis C in the United States","volume":"13","author":"Alter","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0031-1297923","article-title":"HCV routes of transmission: what goes around comes around","volume":"31","author":"Alter","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0025","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis","volume":"57","author":"Aspinall","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2015.03.039_bib0030","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cis361","article-title":"Global burden of hepatitis C: considerations for healthcare providers in the United States","volume":"55","author":"Averhoff","year":"2012","journal-title":"Clin. Infec. Dis."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2015.03.039_bib0035","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1086\/427475","article-title":"Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment","volume":"40","author":"Backmund","year":"2005","journal-title":"Clin. Infec. Dis."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0040","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11524-009-9399-7","article-title":"Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial\/ethnic composition and need","volume":"86","author":"Cooper","year":"2009","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0050","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2105\/AJPH.2009.184580","article-title":"Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors\u2019 use of sterile syringes","volume":"101","author":"Cooper","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1090198114529131","article-title":"Community impact of pharmacy-randomized intervention to improve access to syringes and services for injection drug users","volume":"41","author":"Crawford","year":"2014","journal-title":"Health Educ. Behav"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0060","article-title":"Providing ART to HIV seropositive persons who use drugs: progress in New York City, prospects for ending the epidemic","author":"Des Jarlais","year":"2015","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2105\/AJPH.90.7.1112","article-title":"Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990\u20131997","volume":"90","author":"Des Jarlais","year":"2000","journal-title":"Am. J. Public Health"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2015.03.039_bib0070","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.2105\/AJPH.2008.159327","article-title":"Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs","volume":"99","author":"Des Jarlais","year":"2009","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10461-013-0664-0","article-title":"Combined HIV Prevention, the New York City Condom Distribution Program, and the evolution of safer sex behavior among persons who inject drugs in New York City","volume":"18","author":"Des Jarlais","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2008.11.007","article-title":"Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City","volume":"101","author":"Des Jarlais","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.12.028","article-title":"HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors","volume":"109","author":"Des Jarlais","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.1989.03420070058030","article-title":"HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987","volume":"261","author":"Des Jarlais","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jama.271.2.121","article-title":"Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992","volume":"271","author":"Des Jarlais","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jsat.2013.09.004","article-title":"Transitions from injecting to non-injecting drug use: potential protection against HCV infection","volume":"46","author":"Des Jarlais","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0105","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2105\/AJPH.2003.036517","article-title":"HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services","volume":"95","author":"Des Jarlais","year":"2005","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0110","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990\u20132001","volume":"19","author":"Des Jarlais","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0115","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/bmj.323.7322.1164","article-title":"Treatment of chronic hepatitis","volume":"323","author":"Gow","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1300\/J069v27n02_04","article-title":"Current approaches to HCV infection in current and former injection drug users","volume":"27","author":"Grebely","year":"2008","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.01.002","article-title":"Can hepatitis C virus infection be eradicated in people who inject drugs?","volume":"104","author":"Grebely","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0130","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/infdis\/jir654","article-title":"Agent, host, and environment: hepatitis C virus in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/10826084.2011.523319","article-title":"Access to sterile syringes for injecting drug users in New York City: politics and perception (1984\u20132010)","volume":"46","author":"Heller","year":"2011","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0145","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2105\/AJPH.2012.301206","article-title":"Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study","volume":"103","author":"Iversen","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0150","series-title":"Check Hep C: A Demonstration Project for Providing Comprehensive Community-based Screening, Linkage and Medical Services to New Yorkers with or at Risk for Chronic Hepatitis C Infection","author":"Jordan","year":"2012"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0155","doi-asserted-by":"crossref","first-page":"e97596","DOI":"10.1371\/journal.pone.0097596","article-title":"Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and Hepatitis C Virus infections","volume":"9","author":"Lansky","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0160","doi-asserted-by":"crossref","first-page":"e97317","DOI":"10.1371\/journal.pone.0097317","article-title":"The Hepatitis C cascade of care: identifying priorities to improve clinical outcomes","volume":"9","author":"Linas","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"Ly","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0170","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.24656","article-title":"Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations","volume":"55","author":"Martin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0180","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2105\/AJPH.2013.301458","article-title":"A randomized trial of a Hepatitis care coordination model in Methadone maintenance treatment","volume":"103","author":"Masson","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0185","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0b013e32801086da","article-title":"Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic","volume":"20","author":"Mehta","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0190","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/hep.1840360703","article-title":"National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2000-June 10\u201312, 2002","volume":"36","author":"National Institutes of Health","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0195","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1002\/hep.510260701","article-title":"Consensus Development Conference Panel Statement: management of Hepatitis C","volume":"26","author":"National Institutes of Health","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1331\/JAPhA.2009.07127","article-title":"Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program","volume":"49","author":"Tesoriero","year":"2009","journal-title":"J. Am. Pharmacol. Assoc."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0210","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Int. Med."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0220","doi-asserted-by":"crossref","first-page":"e103345","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C Virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2015.03.039_bib0225","series-title":"Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection","author":"World Health Organization","year":"2014"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615001957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615001957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T13:54:12Z","timestamp":1537710852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615001957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":45,"alternative-id":["S0376871615001957"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.03.039","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006\u20132013","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}